Mechanism of inhibition of PP2A activity and abnormal hyperphosphorylation of tau by I2(PP2A)/SET.

Mechanism of inhibition of PP2A activity and abnormal hyperphosphorylation of tau by I2(PP2A)/SET.
复制标题

DOI:
10.1016/j.febslet.2011.07.020
复制
发表时间:
2011-09-02
期刊:
影响因子:
3.5
通讯作者:
Iqbal K
Iqbal K
中科院分区:
生物学3区
文献类型:
--
作者:
Arnaud L;Chen S;Liu F;Li B;Khatoon S;Grundke-Iqbal I;Iqbal K

文献摘要

参考文献

被引文献

相似文献

蛋白磷酸酶2a (PP2A)活性在阿尔茨海默病脑中受损,受两种内源性抑制剂调节,其中一种是I2PP2A,一种277个氨基酸的长蛋白,也被称为SET。在这里,我们报道了I2PP2A的氨基端片段(I2NTF; aa 1-175)和羧基端片段(I2CTF; aa 176-277)通过与PP2A的催化亚基PP2Ac结合来抑制PP2A,并导致tau的过度磷酸化。I2CTF的c端酸性区和I2NTF的Val 92对它们与PP2Ac的关联和磷酸酶活性的抑制至关重要。
Protein phosphatase-2A (PP2A) activity, which is compromised in Alzheimer disease brain, is regulated by two endogenous inhibitors, one of them being I2PP2A, a 277 amino acid long protein also known as SET. Here we report that both the amino terminal fragment (I2NTF; aa 1–175) and the carboxy terminal fragment (I2CTF; aa 176–277) of I2PP2A inhibit PP2A by binding to its catalytic subunit PP2Ac and cause hyperphosphorylation of tau. The C-terminal acidic region in I2CTF and Val 92 in I2NTF are essential for their association with PP2Ac and inhibition of the phosphatase activity.
DOI: 10.1016/j.neurobiolaging.2007.03.012
发表时间: 2008-09-01
影响因子: 4.2
作者:
Liu, Gong-Ping;Zhang, Yao;Wang, Jian-Zhi
通讯作者: Wang, Jian-Zhi
DOI: 10.1006/jmbi.1999.2898
发表时间: 1999-07-09
影响因子: 5.6
作者:
Miyaji-Yamaguchi, M;Okuwaki, M;Nagata, K
通讯作者: Nagata, K
DOI: 10.1016/j.molcel.2008.02.017
发表时间: 2008-03-28
期刊: MOLECULAR CELL
影响因子: 16
作者:
Liu, Zhixue;Jang, Sung-Wuk;Ye, Keqiang
通讯作者: Ye, Keqiang
DOI: 10.1111/j.1582-4934.2008.00249.x
发表时间: 2008-01
影响因子: 5.3
作者:
Liu R;Zhou XW;Tanila H;Bjorkdahl C;Wang JZ;Guan ZZ;Cao Y;Gustafsson JA;Winblad B;Pei JJ
通讯作者: Pei JJ
DOI: 10.1016/s0092-8674(01)00196-9
发表时间: 2001-01-12
期刊: CELL
影响因子: 64.5
作者:
Seo, SB;McNamara, P;Chakravarti, D
通讯作者: Chakravarti, D